| Literature DB >> 20332122 |
Hsin-Yuan Fang1, Chia-Ling Chang, Shu-Han Hsu, Chih-Yang Huang, Shu-Fen Chiang, Shiow-Her Chiou, Chun-Hua Huang, Yi-Ting Hsiao, Tze-Yi Lin, I-Ping Chiang, Wen-Hu Hsu, Sumio Sugano, Chih-Yi Chen, Ching-Yuang Lin, Wen-Je Ko, Kuan-Chih Chow.
Abstract
AAA domain-containing 3A (ATAD3A) is a member of the AAA-ATPase family. Three forms of ATAD3 have been identified: ATAD3A, ATAD3B and ATAD3C. In this study, we examined the type and expression of ATAD3 in lung adenocarcinoma (LADC). Expression of ATAD3A was detected by reverse transcription-polymerase chain reaction, immunoblotting, immunohistochemistry and confocal immunofluorescent microscopy. Our results show that ATAD3A is the major form expressed in LADC. Silencing of ATAD3A expression increased mitochondrial fragmentation and cisplatin sensitivity. Serum deprivation increased ATAD3A expression and drug resistance. These results suggest that ATAD3A could be an anti-apoptotic marker in LADC.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20332122 DOI: 10.1242/jcs.062034
Source DB: PubMed Journal: J Cell Sci ISSN: 0021-9533 Impact factor: 5.285